Ligand Pharmaceuticals (LGND) Exchange Rate Effect (2018 - 2026)
Ligand Pharmaceuticals' (LGND) quarterly Exchange Rate Effect came in at -$44000.0 in Q1 2026, down 104.16% year-on-year from $1.1 million in Q1 2025, and up 92.54% quarter-over-quarter from -$590000.0 in Q4 2025.
Ligand Pharmaceuticals (LGND) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Ligand Pharmaceuticals has disclosed Exchange Rate Effect across 6 years of filings, most recently posting -$44000.0 for Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$44000.0, down 104.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 1213.27% YoY), and the FY2025 annual result was $2.4 million, up 301.54% from the prior year.
- Exchange Rate Effect came in at -$44000.0 for Q1 2026 at Ligand Pharmaceuticals, up from -$590000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.8 million in Q3 2025 to a low of -$2.9 million in Q2 2025.
- The 3-year median for Exchange Rate Effect is -$44000.0 (2026), against an average of $163571.4.
- Across the five-year window, Exchange Rate Effect soared 1165.52% in 2025 and slumped 104.16% in 2026, its largest moves.
- Ligand Pharmaceuticals' Exchange Rate Effect stood at -$1.5 million in 2024, then surged by 61.89% to -$590000.0 in 2025, then surged by 92.54% to -$44000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$44000.0 (Q1 2026), -$590000.0 (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,000.00 |
| Mar 31, 2026 | -44,000.00 |
| Dec 31, 2025 | -590,000.00 |
| Dec 31, 2025 | -590,000.00 |
| Sep 30, 2025 | 4.77 Mn |
| Sep 30, 2025 | 4.77 Mn |
| Jun 30, 2025 | -2.88 Mn |
| Jun 30, 2025 | -2.88 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | 377,000.00 |
| Sep 30, 2024 | 377,000.00 |
| Dec 31, 2020 | 50,000.00 |
| Dec 31, 2020 | 50,000.00 |
| Sep 30, 2020 | 110,000.00 |
| Sep 30, 2020 | 110,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 9,000.00 |